Mydicar is under clinical development by Sardocor and currently in Phase II for Systolic Heart Failure. According to GlobalData, Phase II drugs for Systolic Heart Failure have a 67% phase transition ...

Persistent Link: https://ieeexplore.ieee.org/servlet/opac?punumber=10 ...

Main outcome measures: Incidence of coronary vasospasm demonstrated by intracoronary acetylcholine (ACh) testing. Methods: The combined procedure of intracoronary ACh testing and endomyocardial biopsy ...

Despite advances in prevention and optimal medical therapy, coronary artery disease (CAD) remains the leading cause of morbidity and mortality worldwide.

The challenge of intracoronary thrombus burden should first be met by incorporation and utilization of contemporary thrombus classifications and their recent modifications. Thrombus classification ...

PLATO investigators dismiss the paper as nothing new, but some clinicians say that, after 15 years, it’s hard not to have ...

Completed US$7.7 million financing and reverse takeover to take Company public– Chinese partner achieved regulatory approval, setting stage for ...

1 Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China 2 Laboratory of Infectious and Liver Diseases, Institute of Infectious Diseases, West China Hospital of ...

A historic milestone in cardiac surgery was achieved on December 13, 2024, at the Laos-Luxembourg Heart Institute, located ...

Heart Failure, Pathophysiology, Etiology, Reduced Ejection Fraction, Preserved Ejection Fraction, Revascularization, CABG, ...